Alnylam Pharmaceuticals Inc (ALNY)
160.39
+0.34
(+0.21%)
USD |
NASDAQ |
Jun 14, 16:00
160.39
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Return Level: 160.39 for June 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 14, 2024 | 160.39 |
June 13, 2024 | 160.05 |
June 12, 2024 | 159.04 |
June 11, 2024 | 156.43 |
June 10, 2024 | 153.47 |
June 07, 2024 | 152.78 |
June 06, 2024 | 149.30 |
June 05, 2024 | 152.06 |
June 04, 2024 | 149.76 |
June 03, 2024 | 150.45 |
May 31, 2024 | 148.43 |
May 30, 2024 | 150.03 |
May 29, 2024 | 146.93 |
May 28, 2024 | 150.06 |
May 24, 2024 | 147.76 |
May 23, 2024 | 149.38 |
May 22, 2024 | 150.90 |
May 21, 2024 | 149.62 |
May 20, 2024 | 150.24 |
May 17, 2024 | 149.40 |
May 16, 2024 | 151.22 |
May 15, 2024 | 147.40 |
May 14, 2024 | 147.89 |
May 13, 2024 | 149.89 |
May 10, 2024 | 150.47 |
Date | Value |
---|---|
May 09, 2024 | 151.37 |
May 08, 2024 | 152.29 |
May 07, 2024 | 154.33 |
May 06, 2024 | 151.22 |
May 03, 2024 | 152.33 |
May 02, 2024 | 150.31 |
May 01, 2024 | 149.96 |
April 30, 2024 | 143.95 |
April 29, 2024 | 147.36 |
April 26, 2024 | 143.31 |
April 25, 2024 | 143.71 |
April 24, 2024 | 143.80 |
April 23, 2024 | 146.07 |
April 22, 2024 | 145.79 |
April 19, 2024 | 144.41 |
April 18, 2024 | 145.16 |
April 17, 2024 | 145.32 |
April 16, 2024 | 146.72 |
April 15, 2024 | 147.70 |
April 12, 2024 | 148.50 |
April 11, 2024 | 152.09 |
April 10, 2024 | 152.41 |
April 09, 2024 | 155.90 |
April 08, 2024 | 156.04 |
April 05, 2024 | 153.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
69.49
Minimum
Jun 26 2019
241.31
Maximum
Dec 21 2022
157.29
Average
153.28
Median
Feb 16 2022
Total Return Level Benchmarks
BridgeBio Pharma Inc | 27.86 |
Pfizer Inc | 95.49 |
Biomarin Pharmaceutical Inc | 83.51 |
Cytokinetics Inc | 53.93 |
Ionis Pharmaceuticals Inc | 40.65 |